Cargando…
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer
BACKGROUND: The degree of histopathological response after neoadjuvant therapy in locally advanced gastric cancer (GC) is a key determinant of patients' long-term outcome. We aimed to assess the pattern of histopathological regression after two neoadjuvant approaches and its impact on survival...
Autores principales: | Martin-Romano, Patricia, Sola, Jose J, Diaz-Gonzalez, Juan A, Chopitea, Ana, Iragorri, Yohana, Martínez-Regueira, Fernando, Ponz-Sarvise, Mariano, Arbea, Leire, Subtil, Jose C, Cano, David, Ceniceros, Lucia, Legaspi, Jairo, Hernandez, Jose Luis, Rodríguez, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023782/ https://www.ncbi.nlm.nih.gov/pubmed/27537382 http://dx.doi.org/10.1038/bjc.2016.252 |
Ejemplares similares
-
Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse
por: Sala Elarre, Pablo, et al.
Publicado: (2019) -
Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling
por: Martin-Romano, Patricia, et al.
Publicado: (2019) -
PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem?
por: Narayanan, Shruthi, et al.
Publicado: (2021) -
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
por: Zarate, R, et al.
Publicado: (2010) -
Single-Institution Experience in Clinical Trials During the COVID-19 Pandemic in Spain: Not So Bad After All?
por: Rodriguez-Otero, Paula, et al.
Publicado: (2020)